Home
>
National Drug Code (NDC)
>
Tygacil
Tygacil - 0008-4990-20 - (TIGECYCLINE)
Drug Information of Tygacil
| Product NDC: | 0008-4990 |
| Proprietary Name: | Tygacil |
| Non Proprietary Name: | TIGECYCLINE |
| Active Ingredient(s): | 50 mg/5mL & nbsp; TIGECYCLINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tygacil
| Product NDC: | 0008-4990 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021821 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050601 |
Package Information of Tygacil
| Package NDC: | 0008-4990-20 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0008-4990-20) > 50 mL in 1 VIAL, SINGLE-USE (0008-4990-19) |
NDC Information of Tygacil
| NDC Code | 0008-4990-20 |
| Proprietary Name | Tygacil |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0008-4990-20) > 50 mL in 1 VIAL, SINGLE-USE (0008-4990-19) |
| Product NDC | 0008-4990 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TIGECYCLINE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050601 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | TIGECYCLINE |
| Strength Number | 50 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient] |
